FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3003400712> ?p ?o ?g. }

• W3003400712 abstract "Summary and comments (Research Highlights in News and Views of the journal Biomarkers in Medicine) on :Combining the “bottom-up” and “top-down” approaches in pharmacokinetic modelling: Fitting PBPK models to observed clinical data.Nikolaos Tsamandouras, Amin Rostami-Hodjegan, Leon Aarons BJCP, Sep 2013, on linedoi: 10.1111/bcp.12234“How to link biomarkers: by using PBPK models”Translational Medicine approaches impose to use many biomarkers from in vitro ones to clinical endpoints. The integration and articulation of those biomarkers are typically organized by “modelling and simulation” techniques. In this article, the authors delineate the process by which they can combine different approaches of modelling, using the specific example of pharmacokinetics.The article summarizes well the 3 levels of complexity of modelling techniques. The first level is the empirical approach i.e. data are described by a mathematical model chosen on the “best fit”. The second level is best described by being between level 1 and level 3 i.e. it is a so-called “semi-mechanistic” model using in some parts an empirical approach and in other parts a mechanistic approach. The level 3 is the mechanistic model and in pharmacokinetics, it is the complex physiologically based pharmacokinetic (PBPK) model. In this case, all key pathways through which a test drug is expected to go in a living organism, is computed.Recent tendency in drug development is to use more the level 3. This was made possible by improvements in computers and softwares, by increased use of in silico methods and by development of in vitro in vivo extrapolation methods.Numerical sensitivity of a model is often assessed by sensitivity analysis. This type of analysis tries to evaluate the origin of the variability of the model output by assessing different sources of variation included in the model. Ultimately, there is the good advice that all PBPK models should be assessed on the plausibility of the physiological parameters and their assigned range of values.Correlation between parameters must be carefully examined. If there is a high correlation, one of the parameters should be quantified, using a physiologically plausible value.For parameter estimation, 2 aspects are underlined. The authors are suggesting that most of the parameters should be fixed from physiological values and only a few should be estimated by model optimization techniques. Additionally, the reliability of the estimate should be described and this is often a challenging task for non physiologically parameterized values.A very interesting clarification is made between the 2 terms, uncertainty and variability. “Variability refers to differences attributable to environmental or genetic factors” when “Uncertainty is variation that derives from errors in the experimental procedure, measurement, modelling and assumptions of the studied system”.A possibility to incorporate Bayesian statistics approaches into PBPK is discussed. One key advantage is to bring a distribution of probability perspective i.e. sort of variability description. However, a disadvantage is the need for high power, high speed computers and highly (or at least specifically) skilled scientists.Ultimately, good PBPK models are sometimes considered overparameterized because they include many different parameters. The whole body system, sometimes described, encompasses too many dimensions in comparison to the available data. Then, it is reasonable to use techniques such as lumping procedures and semi-mechanistic models instead.The conclusion is driven by common sense and proposes “to develop mechanistically sound models with clinical relevance”. In drug development, mechanistic approaches are often key to resolve difficult hurdles because they permit to identify the key parameter(s) driving the failure of a particular molecule." @default.
• W3003400712 created "2020-02-07" @default.
• W3003400712 creator A5077094129 @default.
• W3003400712 date "2014-01-01" @default.
• W3003400712 modified "2023-09-27" @default.
• W3003400712 title "How to link biomarkers using physiologically based pharmacokinetic models." @default.
• W3003400712 hasPublicationYear "2014" @default.
• W3003400712 type Work @default.
• W3003400712 sameAs 3003400712 @default.
• W3003400712 citedByCount "0" @default.
• W3003400712 crossrefType "journal-article" @default.
• W3003400712 hasAuthorship W3003400712A5077094129 @default.
• W3003400712 hasConcept C104317684 @default.
• W3003400712 hasConcept C111919701 @default.
• W3003400712 hasConcept C112705442 @default.
• W3003400712 hasConcept C185592680 @default.
• W3003400712 hasConcept C185867374 @default.
• W3003400712 hasConcept C2775905019 @default.
• W3003400712 hasConcept C41008148 @default.
• W3003400712 hasConcept C55493867 @default.
• W3003400712 hasConcept C70721500 @default.
• W3003400712 hasConcept C71924100 @default.
• W3003400712 hasConcept C86803240 @default.
• W3003400712 hasConcept C98045186 @default.
• W3003400712 hasConcept C98274493 @default.
• W3003400712 hasConceptScore W3003400712C104317684 @default.
• W3003400712 hasConceptScore W3003400712C111919701 @default.
• W3003400712 hasConceptScore W3003400712C112705442 @default.
• W3003400712 hasConceptScore W3003400712C185592680 @default.
• W3003400712 hasConceptScore W3003400712C185867374 @default.
• W3003400712 hasConceptScore W3003400712C2775905019 @default.
• W3003400712 hasConceptScore W3003400712C41008148 @default.
• W3003400712 hasConceptScore W3003400712C55493867 @default.
• W3003400712 hasConceptScore W3003400712C70721500 @default.
• W3003400712 hasConceptScore W3003400712C71924100 @default.
• W3003400712 hasConceptScore W3003400712C86803240 @default.
• W3003400712 hasConceptScore W3003400712C98045186 @default.
• W3003400712 hasConceptScore W3003400712C98274493 @default.
• W3003400712 hasLocation W30034007121 @default.
• W3003400712 hasOpenAccess W3003400712 @default.
• W3003400712 hasPrimaryLocation W30034007121 @default.
• W3003400712 hasRelatedWork W1176122741 @default.
• W3003400712 hasRelatedWork W147669512 @default.
• W3003400712 hasRelatedWork W1608678137 @default.
• W3003400712 hasRelatedWork W1980670658 @default.
• W3003400712 hasRelatedWork W2039211165 @default.
• W3003400712 hasRelatedWork W2071629571 @default.
• W3003400712 hasRelatedWork W2078988289 @default.
• W3003400712 hasRelatedWork W2085212599 @default.
• W3003400712 hasRelatedWork W2099640019 @default.
• W3003400712 hasRelatedWork W2110678759 @default.
• W3003400712 hasRelatedWork W2274492504 @default.
• W3003400712 hasRelatedWork W2555774474 @default.
• W3003400712 hasRelatedWork W2565196476 @default.
• W3003400712 hasRelatedWork W2792176500 @default.
• W3003400712 hasRelatedWork W2792780289 @default.
• W3003400712 hasRelatedWork W2884207561 @default.
• W3003400712 hasRelatedWork W2893728762 @default.
• W3003400712 hasRelatedWork W2941304794 @default.
• W3003400712 hasRelatedWork W3163887163 @default.
• W3003400712 hasRelatedWork W3204234525 @default.
• W3003400712 isParatext "false" @default.
• W3003400712 isRetracted "false" @default.
• W3003400712 magId "3003400712" @default.
• W3003400712 workType "article" @default.